Integra LifeSciences Holdings Corporation (IART)

Check out top investors' recommendation for IART
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
62.67
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neurosurgery, U.S. Instruments, U.S. Extremities, U.S. Spine and Other, and International. Its orthopedics products include specialty metal implants for surgery of the extremities, shoulder, and spine; orthobiologic products for repair and grafting of bone; dermal regeneration products and tissue-engineered wound dressings; and nerve and tendon repair products. The company also offers spinal fusion technologies comprising integrated interbody fusion devices, minimally invasive solutions, and deformity correction products; and neurosurgery products, including dural repair products, cerebral spinal fluid management devices, tissue ablation equipment, intracranial monitoring equipment, and cranial stabilization equipment. In addition, it provides instruments products, such as specialty and general surgical instruments, dental instruments, and surgical lighting for sale to hospitals and outpatient surgery centers, as well as physician, veterinarian, and dental practices. The company sells its products directly through various sales forces and distribution channels in the United States, Europe, and internationally. Integra LifeSciences Holdings Corporation was founded in 1989 and is headquartered in Plainsboro, New Jersey.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Steven Lichtman Oppenheimer & Co. Buy   Feb 22, '19     70.00  Feb 22, '20  N/A 
Matthew O'Brien William Blair & Company, L.L.C. Buy   Feb 21, '19     62.00  Feb 21, '20  N/A 
Steven Lichtman Oppenheimer & Co. Buy   Jan 10, '19       Jan 10, '20  N/A 
Bruce Nudell Credit Suisse Buy   Jan 03, '19     56.00  Jan 03, '20  N/A 
Steven Lichtman Oppenheimer & Co. Buy   Oct 02, '18       Oct 02, '19  N/A 
Steven Lichtman Oppenheimer & Co. Buy   Aug 17, '18       Aug 17, '19  N/A 
Bob Hopkins BofA Merrill Lynch Sell   Aug 07, '18     66.00  Aug 07, '19  N/A 
Steven Lichtman Oppenheimer & Co. Buy   Jun 01, '18     74.00  Jun 01, '19  N/A 
Steven Lichtman Oppenheimer & Co. Buy   Feb 28, '18     60.00  Feb 28, '19  N/A 
Steven Lichtman Oppenheimer & Co. Buy   Dec 12, '17     58.00  Dec 12, '18  N/A 
Jayson Bedford Raymond James Buy   Dec 12, '17     54.00  Dec 12, '18  N/A 
Matt Miksic Piper Jaffray Buy   Oct 31, '17     57.00  Oct 31, '18  N/A 
Matthew O'Brien William Blair & Company, L.L.C. Buy   Oct 26, '17       Oct 26, '18  N/A 
Steven Lichtman Oppenheimer & Co. Buy   Oct 26, '17       Oct 26, '18  N/A 
Raj Denhoy Jefferies & Co. Buy   Oct 10, '17     58.00  Oct 10, '18  N/A 
Steven Lichtman Oppenheimer & Co. Buy   Sep 18, '17     60.00  Sep 18, '18  N/A 
Matthew O'Brien William Blair & Company, L.L.C. Buy   Sep 11, '17     56.00  Sep 11, '18  N/A 
Raj Denhoy Jefferies & Co. Buy   Sep 08, '17     58.00  Sep 08, '18  N/A 
Jayson Bedford Raymond James Buy   Jul 27, '17     55.00  Jul 27, '18  N/A 
Steven Lichtman Oppenheimer & Co. Buy   Jul 26, '17       Jul 26, '18  N/A 
< previous123